Pancreatic cancer reprograms nerve cells to fuel its growth, but blocking these connections can shrink tumors and boost treatment effectiveness.
Pancreatic cancer is closely linked to the nervous system, according to researchers from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM). Their recent study, published in Nature, reveals that pancreatic tumors actively reprogram neurons to support their growth.
In experiments with mice, the researchers found that blocking nerve function not only slowed tumor progression but also made cancer cells more responsive to certain chemotherapy and immunotherapy treatments.
Over the past several years, scientists have observed interactions between cancer and the nervous system in nearly all studied tumor types, often finding that these interactions help tumors grow and survive. Pancreatic cancer, in particular, is surrounded by a dense network of nerves. However, only nerve fibers extend into the tumor, while the main bodies of the nerve cells remain in distant ganglia, the control centers of the peripheral nervous system. Until now, the exact molecular interactions between these nerves and cancer cells remained unclear.
Using a newly developed method, a team led by Andreas Trumpp, DKFZ, and HI-STEM, has now succeeded for the first time in molecularly examining the nerve cells in both healthy tissue and pancreatic cancer in mice.
Pancreatic cancer reprograms nerve cells
In pancreatic tumors, the nerves are extremely well-ramified and in contact with most of the tumor cells. Through the detailed molecular analysis of the individual neurons in the tumor, the researchers discovered that pancreatic cancer reprograms the gene activity of the nerves for its own benefit. The activity of many genes is increased or attenuated, resulting in a tumor-specific signature.
What is more, even after surgical removal of the primary tumor, the tumor nervous system retained its cancer-promoting properties: when the scientists reimplanted pancreatic cancer cells into the animals that had undergone surgery, the resulting secondary tumors were twice as large as those of mice that had been transplanted with pancreatic cancer cells for the first time.
In addition to their direct interaction with cancer cells, nerve cells influence in particular the fibroblasts of the tumor (CAF – cancer-associated fibroblasts), which make up a large part of the tumor mass. They are also stimulated to grow and contribute significantly to the suppression of the immune defense in the tumor environment.
Nerves cut – tumors shrink
When the sympathetic nerve connections to the pancreas were surgically severed or destroyed with special neurotoxins, tumor growth was significantly inhibited. At the same time, the activity of growth-promoting genes in the cancer cells as well as in the CAFs decreased. In the CAFs, the researchers observed a significant increase in pro-inflammatory gene activity after the nerves were destroyed.
“Apparently, the neuronal connections in pancreatic cancer suppress the pro-inflammatory activity of the fibroblasts, thereby inhibiting the cancer defense by immune cells,” explains Vera Thiel, the first author of the paper.
Severed nerves increase the effectiveness of immunotherapies
If the interruption of nerve connections apparently has an inflammatory effect, i.e. activates the immune system, this could increase the effectiveness of an immunotherapy with so-called checkpoint inhibitors (ICI). Drugs in this group metaphorically speaking release the “brakes” of the immune system. However, they cannot combat pancreatic carcinomas on their own: the tumors are considered immunologically “cold”, meaning the therapeutically important T-cells simply cannot reach the tumor.
When the researchers blocked the neural connection to the pancreatic tumor in a mouse model using a targeted neurotoxin, the tumor became sensitive to the checkpoint inhibitor nivolumab again and the tumor mass shrank to one-sixth of the mass in control animals. “By blocking the nerves, were able to convert an immunologically cold tumor into one that was sensitive to immunotherapy,” says Simon Renders, also a first author of the publication, summarizing the result.
Severed nerves plus chemotherapy: synergistic effect
The drug nab-paclitaxel is a component of standard chemotherapy for pancreatic cancer. In addition to inhibiting cell division, it also affects sensory nerves, which is why peripheral neuropathy is one of the known severe side effects of this agent.
Trumpp’s team showed that under repeated cycles of nab-paclitaxel, the sensory nerve fibers in the tumor decreased drastically. The tumor mass also decreased as expected. The effect on sensory nerves apparently seems to be part of the drug’s effectiveness against pancreatic cancer. However, the remaining nerve fibers retained their cancer-promoting gene activity even under treatment.
But what happens when the tumor is completely cut off from its neuronal connections? The researchers achieved this by treating the mice with nab-paclitaxel (to block sensory nerves) and a neurotoxin to switch off the sympathetic neurons. This combination had a synergistic effect and reduced the tumor mass by more than 90 percent.
“The result underscores that both types of nerve cells have functional relevance for tumor growth,” explains Vera Thiel. ”Complete blockade of the communication between nerves and tumor in combination with chemotherapy and/or immune checkpoint inhibitors is a promising approach for combating pancreatic cancer more effectively in the future. For example, it is conceivable to reduce the size of the tumors to such an extent that they subsequently become resectable, Trumpp summarizes. His team, together with doctors from Heidelberg University Hospital, is already planning early clinical trials to test this strategy in pancreatic cancer patients.
The Heidelberg Institute for Stem Cell Research and Experimental Medicine (HI-STEM) gGmbH was founded in 2008 as a public-private partnership between the DKFZ and the Dietmar Hopp Foundation and has been funded by the foundation for 15 years now.
Why research in mice is necessary for this research project
To investigate which different types of peripheral nerves influence the development of pancreatic cancer, the fully developed nervous system of an intact organism is essential. In addition, the aim of the work was to examine the interaction between the nervous system and the tumor as a potential target for new therapeutic approaches. In order to discover possible synergies with the body’s own defense system, the immune system with all its components is also needed. Both cannot be reproduced in cell or organ culture systems.
Reference: “Characterization of single neurons reprogrammed by pancreatic cancer” by Vera Thiel, Simon Renders, Jasper Panten, Nicolas Dross, Katharina Bauer, Daniel Azorin, Vanessa Henriques, Vanessa Vogel, Corinna Klein, Aino-Maija Leppä, Isabel Barriuso Ortega, Jonas Schwickert, Iordanis Ourailidis, Julian Mochayedi, Jan-Philipp Mallm, Carsten Müller-Tidow, Hannah Monyer, John Neoptolemos, Thilo Hackert, Oliver Stegle, Duncan T. Odom, Rienk Offringa, Albrecht Stenzinger, Frank Winkler, Martin Sprick and Andreas Trumpp, 17 February 2025, Nature.
DOI: 10.1038/s41586-025-08735-3

News
Specially engineered antibody delivers RNA therapy to treatment-resistant tumors
Elias Quijano, PhD; Diana Martinez-Saucedo, PhD; Zaira Ianniello, PhD; and Natasha Pinto-Medici, PhD, there are 25 other contributors, most from Yale's Department of Therapeutic Radiology and from the departments of genetics, molecular biophysics and [...]
Vaccinated women face fewer cervical cancer risks
New data from Denmark shows the HPV vaccine’s powerful long-term impact, while also revealing why cervical cancer screening is still essential. A Danish study published in the journal Eurosurveillance reports that women who received the human [...]
3D-printed implant offers a potential new route to repair spinal cord injuries
A research team at RCSI University of Medicine and Health Sciences has developed a 3-D printed implant to deliver electrical stimulation to injured areas of the spinal cord, offering a potential new route to [...]
Nanocrystals Carrying Radioisotopes Offer New Hope for Cancer Treatment
The Science Scientists have developed tiny nanocrystal particles made up of isotopes of the elements lanthanum, vanadium, and oxygen for use in treating cancer. These crystals are smaller than many microbes and can carry isotopes of [...]
New Once-a-Week Shot Promises Life-Changing Relief for Parkinson’s Patients
A once-a-week shot from Australian scientists could spare people with Parkinson’s the grind of taking pills several times a day. The tiny, biodegradable gel sits under the skin and releases steady doses of two [...]
Weekly injectable drug offers hope for Parkinson’s patients
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the University of South Australia [...]
Most Plastic in the Ocean Is Invisible—And Deadly
Nanoplastics—particles smaller than a human hair—can pass through cell walls and enter the food web. New research suggest 27 million metric tons of nanoplastics are spread across just the top layer of the North [...]
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]